Simultaneously, these medications suppress glucagon secretion from pancreatic alpha cells, further contributing to improved glycemic control
February 2025 The FDA issued additional warnings about the risks of gastroparesis associated with GLP-1 receptor agonists, emphasizing the need for comprehensive patient education about potential complications [1]
R., Chinnaswamy P., Thulasingam S
The influence of GLP-1 medications extends far beyond the products marketed to users
Kidney Dysfunction : Excessive use of glutathione, especially in IV form, can strain the kidneys
Human embryonic stem cells raise numerous ethical questions, and their use is governed by regulatory frameworks established by entities like the National Institutes of Health